U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

The Food and Drug Administration gave emergency authorization to Ellume's rapid test in December, after it showed 96% accuracy in a U.S. clinical study.

Copyright 2021 NPR

  • Facebook
  • Twitter
  • LinkedIn
  • Email
Bill Chappell is a writer and editor on the News Desk in the heart of NPR's newsroom in Washington, D.C.
Selena Simmons-Duffin reports on health policy for NPR.